Appointment of Joint Broker
In brief · summary, not quotable
No summary for this filing – the full text is below.
Full announcement
Select text to share a quote on X · sign in to keep highlights & notes in your POLB notes
30 April 2024 - Poolbeg Pharma Plc (AIM: POLB, OTCQB: POLBF, 'Poolbeg' or the 'Company'), a biopharmaceutical company focussed on the development and commercialisation of innovative medicines targeting diseases with a high unmet medical need, has appointed Shore Capital Stockbrokers Limited as its Joint Broker with immediate effect.
Cavendish Capital Markets Ltd remains as the Company's Nominated Adviser and Joint Broker alongside J&E Davy as Joint Broker.
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.